2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2008050513v1 19/12/2282    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Zeisberg, E. M. Articles by Kalluri, R. PubMed PubMed Citation Articles by Zeisberg, E. M. Articles by Kalluri, R. Related Collections Related Articles

Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition

Elisabeth M. Zeisberg^*, Scott E. Potenta^*, Hikaru Sugimoto^*, Michael Zeisberg^* and Raghu Kalluri^*,,

^* Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Department of Biological Chemistry and Molecular Pharmacology, and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts

Correspondence: Dr. Raghu Kalluri, Department of Medicine, Harvard Medical School, Division of Matrix Biology, Department of Medicine, CLS 11086, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, 3 Blackfan Circle, Boston, MA 02215. Phone: 617-735-4601; Fax: 617-735-4602; E-mail: rkalluri{at}bidmc.harvard.edu

Received for publication May 19, 2008. Accepted for publication August 18, 2008.

Fibroblasts are key mediators of fibrosis in the kidney and other organs, but their origin during fibrosis is still not completely clear. Activated fibroblasts likely arise from resident quiescent fibroblasts via epithelial-to-mesenchymal transition and from the bone marrow. Here, we demonstrate that endothelial cells also contribute to the emergence of fibroblasts during kidney fibrosis via the process of endothelial-to-mesenchymal transition (EndMT). We examined the contribution of EndMT to renal fibrosis in three mouse models of chronic kidney disease: (1) Unilateral ureteral obstructive nephropathy, (2) streptozotocin-induced diabetic nephropathy, and (3) a model of Alport renal disease. Approximately 30 to 50% of fibroblasts coexpressed the endothelial marker CD31 and markers of fibroblasts and myofibroblasts such as fibroblast specific protein-1 and -smooth muscle actin. Endothelial lineage tracing using Tie2-Cre;R26R-stop-EYFP transgenic mice further confirmed the presence of EndMT-derived fibroblasts. Collectively, our results demonstrate that EndMT contributes to the accumulation of activated fibroblasts and myofibroblasts in kidney fibrosis and suggest that targeting EndMT might have therapeutic potential.

Related Articles

This Month's Highlights
J. Am. Soc. Nephrol. 2008 19: A10. [Full Text] [PDF]

This article has been cited by other articles:

				F. Strutz How Many Different Roads May a Cell Walk down in Order to Become a Fibroblast? J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2246 - 2248. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673